Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.

<h4>Unlabelled</h4>(18)F-FP-(+)-DTBZ is a novel PET radiotracer targeting vesicular monoamine transporter type 2 (VMAT2). The goal was to explore the image features in normal human brains with (18)F-FP-(+)-DTBZ as a reference of molecular landmark for clinical diagnosis in Parkinson'...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kun-Ju Lin, Yi-Hsin Weng, Chia-Ju Hsieh, Wey-Yil Lin, Shiaw-Pyng Wey, Mei-Ping Kung, Tzu-Chen Yen, Chin-Song Lu, Ing-Tsung Hsiao
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e5d6de1646864c16b9d114f7ac54fb1c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e5d6de1646864c16b9d114f7ac54fb1c
record_format dspace
spelling oai:doaj.org-article:e5d6de1646864c16b9d114f7ac54fb1c2021-11-18T08:53:15ZBrain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.1932-620310.1371/journal.pone.0075952https://doaj.org/article/e5d6de1646864c16b9d114f7ac54fb1c2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24098749/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Unlabelled</h4>(18)F-FP-(+)-DTBZ is a novel PET radiotracer targeting vesicular monoamine transporter type 2 (VMAT2). The goal was to explore the image features in normal human brains with (18)F-FP-(+)-DTBZ as a reference of molecular landmark for clinical diagnosis in Parkinson's disease (PD) and related disorders.<h4>Materials and methods</h4>A total of 22 healthy subjects (59.3±6.0 years old) including 7 men and 15 women were recruited for MRI and (18)F-FP-(+)-DTBZ PET scans. A total number of 55 brain VOIs were selected for quantitation analysis. The regional specific uptake ratio (SUR) was calculated with occipital as reference from MRI-based spatially normalized (18)F-FP-(+)-DTBZ images. Regional percentage SUR to that of anterior putamen was calculated. Average SUR images were displayed in 2D and 3D space to illustrate the image patterns. The correlation between age and regional VMAT2 uptake was also examined.<h4>Results</h4>Visual assessment showed symmetric uptake of (18)F-FP-(+)-DTBZ and obviously highest in striatum, followed by nucleus accumbens, hypothalamus, substantia nigra, and raphe nuclei. Quantification analysis revealed striatal VMAT2 density of anterior putamen>posterior putamen>caudate nucleus. Other subcortical regions were with moderate VMAT2 distribution (6∼51% SUR of anterior putamen), while slightly lower VMAT2 was observed in cerebellum (10.60% SUR) and much lower in neocortex (<5% SUR). No significant correlation of SUR to age was found in subcortical regions.<h4>Conclusion</h4>Using (18)F-FP-(+)-DTBZ PET, we showed the 2D and 3D imaging features of the VMAT2 distribution in vivo in healthy aging brains. The in vivo imaging characteristics of VMAT2 is consistent with the expression of VMAT2 in a recent autopsy study. Therefore, 3D visualization and higher image quality of (18)F-FP-(+)-DTBZ PET imaging might potentially be a powerful biomarker in detecting VMAT2 distribution of subcortical regions, and for Parkinson's disease and related neuropsychiatric disorders involving related monoaminergic systems.Kun-Ju LinYi-Hsin WengChia-Ju HsiehWey-Yil LinShiaw-Pyng WeyMei-Ping KungTzu-Chen YenChin-Song LuIng-Tsung HsiaoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 9, p e75952 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kun-Ju Lin
Yi-Hsin Weng
Chia-Ju Hsieh
Wey-Yil Lin
Shiaw-Pyng Wey
Mei-Ping Kung
Tzu-Chen Yen
Chin-Song Lu
Ing-Tsung Hsiao
Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.
description <h4>Unlabelled</h4>(18)F-FP-(+)-DTBZ is a novel PET radiotracer targeting vesicular monoamine transporter type 2 (VMAT2). The goal was to explore the image features in normal human brains with (18)F-FP-(+)-DTBZ as a reference of molecular landmark for clinical diagnosis in Parkinson's disease (PD) and related disorders.<h4>Materials and methods</h4>A total of 22 healthy subjects (59.3±6.0 years old) including 7 men and 15 women were recruited for MRI and (18)F-FP-(+)-DTBZ PET scans. A total number of 55 brain VOIs were selected for quantitation analysis. The regional specific uptake ratio (SUR) was calculated with occipital as reference from MRI-based spatially normalized (18)F-FP-(+)-DTBZ images. Regional percentage SUR to that of anterior putamen was calculated. Average SUR images were displayed in 2D and 3D space to illustrate the image patterns. The correlation between age and regional VMAT2 uptake was also examined.<h4>Results</h4>Visual assessment showed symmetric uptake of (18)F-FP-(+)-DTBZ and obviously highest in striatum, followed by nucleus accumbens, hypothalamus, substantia nigra, and raphe nuclei. Quantification analysis revealed striatal VMAT2 density of anterior putamen>posterior putamen>caudate nucleus. Other subcortical regions were with moderate VMAT2 distribution (6∼51% SUR of anterior putamen), while slightly lower VMAT2 was observed in cerebellum (10.60% SUR) and much lower in neocortex (<5% SUR). No significant correlation of SUR to age was found in subcortical regions.<h4>Conclusion</h4>Using (18)F-FP-(+)-DTBZ PET, we showed the 2D and 3D imaging features of the VMAT2 distribution in vivo in healthy aging brains. The in vivo imaging characteristics of VMAT2 is consistent with the expression of VMAT2 in a recent autopsy study. Therefore, 3D visualization and higher image quality of (18)F-FP-(+)-DTBZ PET imaging might potentially be a powerful biomarker in detecting VMAT2 distribution of subcortical regions, and for Parkinson's disease and related neuropsychiatric disorders involving related monoaminergic systems.
format article
author Kun-Ju Lin
Yi-Hsin Weng
Chia-Ju Hsieh
Wey-Yil Lin
Shiaw-Pyng Wey
Mei-Ping Kung
Tzu-Chen Yen
Chin-Song Lu
Ing-Tsung Hsiao
author_facet Kun-Ju Lin
Yi-Hsin Weng
Chia-Ju Hsieh
Wey-Yil Lin
Shiaw-Pyng Wey
Mei-Ping Kung
Tzu-Chen Yen
Chin-Song Lu
Ing-Tsung Hsiao
author_sort Kun-Ju Lin
title Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.
title_short Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.
title_full Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.
title_fullStr Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.
title_full_unstemmed Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.
title_sort brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18f-fp-(+)-dtbz pet.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/e5d6de1646864c16b9d114f7ac54fb1c
work_keys_str_mv AT kunjulin brainimagingofvesicularmonoaminetransportertype2inhealthyagingsubjectsby18ffpdtbzpet
AT yihsinweng brainimagingofvesicularmonoaminetransportertype2inhealthyagingsubjectsby18ffpdtbzpet
AT chiajuhsieh brainimagingofvesicularmonoaminetransportertype2inhealthyagingsubjectsby18ffpdtbzpet
AT weyyillin brainimagingofvesicularmonoaminetransportertype2inhealthyagingsubjectsby18ffpdtbzpet
AT shiawpyngwey brainimagingofvesicularmonoaminetransportertype2inhealthyagingsubjectsby18ffpdtbzpet
AT meipingkung brainimagingofvesicularmonoaminetransportertype2inhealthyagingsubjectsby18ffpdtbzpet
AT tzuchenyen brainimagingofvesicularmonoaminetransportertype2inhealthyagingsubjectsby18ffpdtbzpet
AT chinsonglu brainimagingofvesicularmonoaminetransportertype2inhealthyagingsubjectsby18ffpdtbzpet
AT ingtsunghsiao brainimagingofvesicularmonoaminetransportertype2inhealthyagingsubjectsby18ffpdtbzpet
_version_ 1718421234891358208